onclive· 2mo ago
save<![CDATA[Planned HERIZON-GEA-01 Analyses and the Doublet-vs-Triplet Question]]>
May 14, 2026read original ↗
<![CDATA[New HER2+ gastric cancer data show triplet immunotherapy boosts survival and durable responses, hinting immune activation beyond HER2 targets.]]>
The original article is no longer reachable from this URL.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that